Immunogenicity for Biologics 2012
February 21 - 22, 2012(Ended)
Lancaster London
London, United Kingdom
London, United Kingdom
Immunogenicity for Biologics is a conference that covers topics such as:
- Methodology to detect the ADA response and development of an ADA assay as an alternative assay, rather than ELISA assays
- Clarification of FDA guidelines regarding assay development for immunogenicity testing and validation for both ELISA and cell-based assays
- How bioassays work in conjunction with PK and PD
- Conducting immunogenicity testing of the originator product compared to the biosimilar/biobetter
- The importance of monitoring immunogenicity at the pre-clinical/clinical stage of development
- Regulations behind applications of ligand-binding antibodies, cell-based assays and acid dissociation assays
Immunogenicity for Biologics brings together Directors, Heads of Department, Team Leaders, Managers, Consultants, Associates and Coordinators from CEE Regulatory Affairs, Regulatory Affairs, Global Regulatory Affairs, CIS Regulatory Affairs, Registration, Medical Affairs, Business Development and International Strategy.
Venue
Address
Lancaster Terrace,
London,
United Kingdom
London,
United Kingdom
Prices *
1699-2997 Pound Sterling
Organization
Categories
Concurrent events
- SES London 2012 - London
- World Generic Medicines Congress Europe 2012 - London
- Advances and Progress in Drug Design 2012 - London
- CPO Exchange 2012 - London
- Retail Shopfitting & Display Summit 2012 - London
- Product Management for Telecoms and IT 2012 - London
- Objective Capital Americas Resources Congress 2012 - London
- Global Nuclear Supply Chain & Enhancement Forum (GNSCE 2012) - London
- Workplace Futures 2012 - London
- Turing lecture 2012 - London
Important
Please, check the conference website for possible changes, before you make any traveling
arrangements
* Prices are for evaluation only.
Articles/News/Press releases
- Health conferences
- Correlation existing between the decreasing values of central corneal thickness and worsening of the field defect in primary open angle glaucoma (Health/Opthalmology)
- Groundwater Development - The hydrogeological conditions in the Wadi Dara, Eastern Desert, Egypt
- Cancer Basic Research
- Chronic lymphocytic leukemia and related disorders - Clinical
- Effect of pegylated interferon and ribavirin used for treatment of chronic hepatitis C patients on semen parameters
